Actualités

The unsuspected role of PD-1 molecule in mycobacterial infections

An innovative process to optimize blood stem cell transplantation

Identification of a first genetic cause for tree-man syndrome (cutaneous papillomavirus)

Entrepreneurs and friends of Imagine - Working together to change the lives of children and families affected by genetic diseases

Discovery of a new gene responsible of syndromes causing aortic aneurysms

AtmosR, Medetia and Institut Imagine launch collaboration to develop a treatment for Ondine syndrome

COVID-19 and multisystemic inflammatory syndrome in children: 75% of affected children have the same immune abnormality

Identification of a new genetic cause of intellectual disability

An innovative method to characterize each cell individually

Romane Thouenon, a doctoral student involved in research and with young researchers

Portrait - Marc Chevalier, Head of Bioentrepreneurship

Discovery of a new genetic disease predisposing to mycobacterial infections

A new treatment discovered at Institut Imagine and developed by QED Therapeutics enters clinical trial with a first child with achondroplasia in France

Testimony of Patrice Brion

Institut Imagine accelerates research on autism spectrum disorders